ArticleNeuro-oncology2017

Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma.

Tara A Barone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.